The firm promises to produce millions of vaccine doses to in the case of an influenza pandemic.

Eppendorf experts discuss regulatory challenges, single-use technologies, and digitalization strategies for scaling from R&D to commercial manufacturing.

A research team from London examined the relationship between adenovirus-associated virus (AAV)-based vectors and liver ...

Last month, large pharmaceutical conglomerate Merck filed a worker adjustment and retraining notification (WARN) notice with ...

In a year dominated by onshoring stories, Aragen has seized the advantages of running a biotech business in India.

Explore the latest news and expert commentary by Lakshmana Kumar Arlagadda, brought to you by the Contributor of BioProcess ...

Explore the latest news and expert commentary by G. Krishna Prasad, brought to you by the Contributor of BioProcess ...

Ireland’s biopharmaceutical sector continues to thrive amid key financial incentives, proximity to key markets, and favorable regulatory frameworks.

Explore the latest news and expert commentary by Fiona Ford, brought to you by the Contributor of BioProcess International.

Explore the latest news and expert commentary by Melissa Nixon, brought to you by the Contributor of BioProcess International ...

Modernizing biomanufacturing methods and reducing regulatory burdens are key landmarks on India’s roadmap for expanding biosimilars development.

The US Food and Drug Administration (FDA) announced the launch of a new framework to expedite therapies for ultra-rare diseases. The program will focus on targeted, individualized treatments for ...